Posted by ABMN Staff on Apr 20th, 2024
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Analysts at Wedbush reduced their Q1 2024 earnings estimates for Sage Therapeutics in a research note issued to investors on Wednesday, April 17th. Wedbush analyst...
More of this article »